← Back to Search

Behavioral Intervention

Pelvic Floor Muscle Training for Myotonic Dystrophy

N/A
Waitlist Available
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to investigate the effectiveness of pelvic floor muscle (PFM) training in treating urinary incontinence in women with Myotonic dystrophy type 1 (DM1). The study will

Who is the study for?
This trial is for women with Myotonic Dystrophy type 1 (DM1) who experience urinary incontinence. Participants should have a confirmed diagnosis of DM1 and be dealing with issues related to pelvic floor muscle weakness.
What is being tested?
The study tests the effectiveness of a 12-week Pelvic Floor Muscle Training program, which includes weekly sessions with a physiotherapist and exercises at home, on reducing urinary incontinence in women with DM1.
What are the potential side effects?
While not explicitly mentioned, pelvic floor training generally has minimal side effects but may include temporary soreness or fatigue from the exercises.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through treatment completion (session 1 to 12; 12 weeks of treatment)
This trial's timeline: 3 weeks for screening, Varies for treatment, and through treatment completion (session 1 to 12; 12 weeks of treatment) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Intervention Acceptability Questionnaire
Percentage of attended treatment sessions
Percentage of home exercises performed
+2 more
Secondary study objectives
Change in pelvic floor disorder symptoms
Change in pelvic floor disorder symptoms related impact on quality of life
Change in pelvic floor muscles function
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Pelvic floor muscle trainingExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pelvic floor muscle training
2022
Completed Phase 3
~2690

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
304 Previous Clinical Trials
76,717 Total Patients Enrolled
1 Trials studying Myotonic Dystrophy
12 Patients Enrolled for Myotonic Dystrophy
Interdisciplinary research team on neuromuscular diseases (GRIMN)UNKNOWN
Centre de recherche du Centre hospitalier universitaire de SherbrookeOTHER
61 Previous Clinical Trials
33,502 Total Patients Enrolled
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top